Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Show: All - Companies - Funds
Results 1 - 21 of about 100 companies and 1 funds for John D. Parker
Company Exchange Symbol Last price Quote change Market cap
Nike Inc NYSE NKE 93.00 +1.05 (1.14%) 79.22B
NIKE, Inc. (NIKE) is engaged in the design, development and worldwide marketing and selling of footwear, apparel, equipment, accessories and services.
Executive:
John F. Slusher
Geron Corporation NASDAQ GERN 2.21 -0.05 (-2.21%) 354.65M
Geron Corporation (Geron) is a clinical-stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid ...
Executive:
John A. Scarlett MD
Sangamo Biosciences, Inc. NASDAQ SGMO 11.91 +0.04 (0.34%) 811.96M
Sangamo BioSciences, Inc. is a clinical stage biopharmaceutical company. The Company is engaged in the research, development and commercialization of zinc ...
Executive:
John W. Larson
iShares NASDAQ Biotechnology Index (ETF) NASDAQ IBB 296.70 +6.07 (2.09%) 6.15B
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment ...
Executive:
John E. Kerrigan
iShares MSCI Brazil Index (ETF) NYSEARCA EWZ 42.75 +1.65 (4.01%) 5.37B
iShares MSCI Brazil Capped Index Fund (the Fund), formerly iShares MSCI Brazil Index Fund, seeks to provide investment results that correspond generally to ...
Executive:
John E. Kerrigan
American Airlines Group Inc OTCMKTS AAMRQ 11.39 0.00 (0.00%) 3.82B
American Airlines Group Inc., formerly AMR Corporation, operates in the airline industry. The Company's principal subsidiary is American Airlines, Inc.
Executive:
John T. Cahill
iShares Barclays TIPS Bond Fund (ETF) NYSEARCA TIP 112.99 -0.04 (-0.04%) 12.32B
iShares TIPS Bond ETF (the Fund), formerly iShares Barclays Treasury Inflation Protected Securities Bond Fund, is an exchange-traded fund (ETF).
Executive:
John E. Kerrigan
CIT Group Inc. NYSE CIT 48.60 +0.11 (0.23%) 9.00B
CIT Group Inc. is a bank holding company (BHC) together with its owned subsidiaries (CIT), provides primarily commercial financing and leasing products and ...
Executive:
John A. Thain
iShares Select Dividend ETF NYSEARCA DVY 77.58 +0.97 (1.27%) 14.69B
iShares Select Dividend ETF, formerly iShares Dow Jones Select Dividend Index Fund (the Fund), is an exchange-traded fund. The Fund seeks investment results ...
Executive:
John E. Kerrigan
iShares S&P MidCap 400 Growth (ETF) NYSEARCA IJK 154.48 +0.38 (0.25%) 4.53B
iShares S&P Mid-Cap 400 Growth ETF, formerly iShares S&P MidCap 400 Growth Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment ...
Executive:
John E. Kerrigan
iShares Dow Jones US Real Estate (ETF) NYSEARCA IYR 74.42 +0.63 (0.85%) 5.41B
iShares US Real Estate ETF, formerly iShares Dow Jones US Real Estate Index Fund (the Fund), is a non-diversified fund. The Fund seeks investment results ...
Executive:
John E. Kerrigan
iShares S&P SmallCap 600 Growth (ETF) NYSEARCA IJT 118.23 +0.98 (0.84%) 2.66B
iShares S&P Small-Cap 600 Growth ETF, formerly iShares S&P SmallCap 600 Growth Index Fund (the Fund), seeks investment results that correspond generally to ...
Executive:
John E. Kerrigan
Coca-Cola Enterprises Inc NYSE CCE 43.13 +0.13 (0.30%) 10.39B
Coca-Cola Enterprises, Inc. (CCE) markets, produces, and distributes nonalcoholic beverages. The Company serves a market of approximately 170 million ...
Executive:
John F. Brock
iShares Cohen & Steers Realty Maj. (ETF) NYSEARCA ICF 92.46 +0.62 (0.68%) 3.04B
iShares Cohen & Steers REIT ETF (the Fund), formerly iShares Cohen & Steers Realty Majors Index Fund, is an exchange-traded fund (ETF).
Executive:
John E. Kerrigan
iShares Dow Jones US Brok-Dea. Ind.ETF NYSEARCA IAI 39.52 -0.03 (-0.08%) 253.12M
iShares US Broker-Dealers ETF (the Fund), formerly iShares Dow Jones US Broker- Dealers Index Fund, is an exchange-traded fund (ETF).
Executive:
John E. Kerrigan
OncoGenex Pharmaceuticals Inc NASDAQ OGXI 2.25 -0.18 (-7.41%) 51.36M
OncoGenex Pharmaceuticals, Inc. (OncoGenex) is a biopharmaceutical company engaged in the development and commercialization of new cancer therapies that ...
Executive:
John A. Bencich
iShares Russell 1000 Growth Index (ETF) NYSEARCA IWF 92.96 +0.64 (0.69%) 25.40B
iShares Russell 1000 Growth ETF (the Fund), formerly iShares Russell 1000 Growth Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment ...
Executive:
John E. Kerrigan
iShares S&P 500 Growth Index (ETF) NYSEARCA IVW 108.59 +0.79 (0.73%) 11.19B
iShares S&P 500 Growth ETF, formerly iShares S&P 500 Growth Index Fund (the Growth Fund), is an exchange-traded fund. The Fund seeks investment results that ...
Executive:
John E. Kerrigan
iShares MSCI Spain Capped ETF NYSEARCA EWP 37.29 +0.15 (0.40%) 1.96B
iShares MSCI Spain Capped ETF, formerly iShares MSCI Spain Index Fund, is an exchange-traded fund. The Fund seeks to provide investment results that ...
Executive:
John E. Kerrigan
iShares Russell 1000 Value Index (ETF) NYSEARCA IWD 101.14 +0.52 (0.52%) 23.91B
iShares Russell 1000 Value ETF (the Fund), formerly iShares Russell 1000 Value Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment ...
Executive:
John E. Kerrigan
Show all 100 companies »
Mutual Fund Symbol Nav Nav change
Beutel Goodman Balanced Class D BTG772 19.60 +0.02 (0.11%)
The fundamental investment objective of the Balanced Fund is to enhance long- term capital value by investing in cash and cash equivalents, fixed income ...
Executive:
John Christie